Assignee
PROGENICS PHARM INC
US·63 granted patents·31 pending applications·1,216 citations·filing 1993–2024
Top patents by PatentIndex Score
94 records- 0199US12224067B1Network for medical image analysis, decision support system, and related graphical user interface (GUI) applicationsPROGENICS PHARM INC·Filed 2024·Granted Feb 11, 2025·7 cites·34 claims
- 0299US11894141B2Network for medical image analysis, decision support system, and related graphical user interface (GUI) applicationsPROGENICS PHARM INC·Filed 2022·Granted Feb 6, 2024·11 cites·35 claims
- 0399US11424035B2Network for medical image analysis, decision support system, and related graphical user interface (GUI) applicationsPROGENICS PHARM INC·Filed 2020·Granted Aug 23, 2022·18 cites·45 claims
- 0499US10762993B2Network for medical image analysis, decision support system, and related graphical user interface (GUI) applicationsPROGENICS PHARM INC·Filed 2019·Granted Sep 1, 2020·25 cites·21 claims
- 0598US12431246B2Network for medical image analysis, decision support system, and related graphical user interface (GUI) applicationsPROGENICS PHARM INC·Filed 2023·Granted Sep 30, 2025·2 cites·36 claims
- 0697US11544407B1Systems and methods for secure cloud-based medical image upload and processingPROGENICS PHARM INC·Filed 2020·Granted Jan 3, 2023·10 cites·23 claims
- 0797US10665346B2Network for medical image analysis, decision support system, and related graphical user interface (GUI) applicationsPROGENICS PHARM INC·Filed 2019·Granted May 26, 2020·25 cites·13 claims
- 0897US10340046B2Network for medical image analysis, decision support system, and related graphical user interface (GUI) applicationsPROGENICS PHARM INC·Filed 2017·Granted Jul 2, 2019·32 cites·21 claims
- 0996US11937962B2Systems and methods for automated and interactive analysis of bone scan images for detection of metastasesPROGENICS PHARM INC·Filed 2022·Granted Mar 26, 2024·11 cites·30 claims
- 1096US11564621B2Systems and methods for artificial intelligence-based image analysis for cancer assessmentPROGENICS PHARM INC·Filed 2020·Granted Jan 31, 2023·19 cites·21 claims
- 1196US11534125B2Systems and methods for automated and interactive analysis of bone scan images for detection of metastasesPROGENICS PHARM INC·Filed 2020·Granted Dec 27, 2022·15 cites·34 claims
- 1295US11900597B2Systems and methods for artificial intelligence-based image analysis for cancer assessmentPROGENICS PHARM INC·Filed 2020·Granted Feb 13, 2024·12 cites·34 claims
- 1395US7592014B2Stabilized viral envelope proteins and uses thereofPROGENICS PHARM INC·Filed 2005·Granted Sep 22, 2009·34 cites·17 claims
- 1495US7345153B2Compounds capable of inhibiting HIV-1 infectionPROGENICS PHARM INC·Filed 2006·Granted Mar 18, 2008·23 cites·7 claims
- 1594US12414748B2Systems and methods for automated and interactive analysis of bone scan images for detection of metastasesPROGENICS PHARM INC·Filed 2024·Granted Sep 16, 2025·3 cites·24 claims
- 1694US12417533B2Systems and methods for artificial intelligence-based image analysis for cancer assessmentPROGENICS PHARM INC·Filed 2023·Granted Sep 16, 2025·4 cites·20 claims
- 1794US10973486B2Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determinationPROGENICS PHARM INC·Filed 2018·Granted Apr 13, 2021·41 cites·55 claims
- 1894US7674904B2Synthesis of R-N-methylnaltrexonePROGENICS PHARM INC·Filed 2006·Granted Mar 9, 2010·52 cites·24 claims
- 1994US7060273B2Methods for inhibiting HIV-1 infectionPROGENICS PHARM INC·Filed 2002·Granted Jun 13, 2006·32 cites·24 claims
- 2094US6692745B2Compositions and methods for inhibition of HIV-1 infectionPROGENICS PHARM INC·Filed 2000·Granted Feb 17, 2004·37 cites·15 claims
- 2193US7939083B2Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomainPROGENICS PHARM INC·Filed 2007·Granted May 10, 2011·55 cites·21 claims
- 2293US6710173B1Stabilized viral envelope proteins and uses thereofPROGENICS PHARM INC·Filed 2000·Granted Mar 23, 2004·36 cites·30 claims
- 2392US7666419B2Anti-CCR5 antibodyPROGENICS PHARM INC·Filed 2006·Granted Feb 23, 2010·14 cites·36 claims
- 2492US7563899B2(S)-N-methylnaltrexonePROGENICS PHARM INC·Filed 2006·Granted Jul 21, 2009·36 cites·19 claims
- 2592US6548636B2Sulfated CCR5 peptides for HIV-1 infectionPROGENICS PHARM INC·Filed 2001·Granted Apr 15, 2003·54 cites·4 claims
- 2692US6344545B1Method for preventing HIV-1 infection of CD4+ cellsPROGENICS PHARM INC·Filed 1997·Granted Feb 5, 2002·91 cites·6 claims
- 2791US7118859B2Methods for inhibiting HIV-1 infectionPROGENICS PHARM INC·Filed 2001·Granted Oct 10, 2006·30 cites·8 claims
- 2891US7022324B2Stabilized viral envelope proteins and uses thereofPROGENICS PHARM INC·Filed 2001·Granted Apr 4, 2006·31 cites·20 claims
- 2990US8343992B2Synthesis of R-N-methylnaltrexonePROGENICS PHARM INC·Filed 2010·Granted Jan 1, 2013·14 cites·32 claims
- 3090US7138119B2Compositions and methods for inhibition of HIV-1 infectionPROGENICS PHARM INC·Filed 2001·Granted Nov 21, 2006·24 cites·15 claims
- 3189US6034223ANon-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereofPROGENICS PHARM INC·Filed 1995·Granted Mar 7, 2000·69 cites·8 claims
- 3287US5817767ASynergistic composition of CD4-based protein and anti-HIV-1 antibody, and methods of using samePROGENICS PHARM INC·Filed 1993·Granted Oct 6, 1998·73 cites·6 claims
- 3386US9669096B2Stable pharmaceutical formulations of methylnaltrexonePROGENICS PHARM INC·Filed 2013·Granted Jun 6, 2017·5 cites·39 claims
- 3486US9597327B2Synthesis of (R)-N-methylnaltrexonePROGENICS PHARM INC·Filed 2015·Granted Mar 21, 2017·5 cites·26 claims
- 3586US6261763B1Fluorescence resonance energy transfer screening assay for the identification of compounds that are capable of abrogating macrophage-tropic HIV-1 cell fusionPROGENICS PHARM INC·Filed 1996·Granted Jul 17, 2001·38 cites·9 claims
- 3686US6107019AMethod for preventing HIV-1 infection of CD4+ cellsPROGENICS PHARM INC·Filed 1997·Granted Aug 22, 2000·78 cites·12 claims
- 3783US10376584B2Stable pharmaceutical formulations of methylnaltrexonePROGENICS PHARM INC·Filed 2017·Granted Aug 13, 2019·2 cites·15 claims
- 3883US7851600B2Anti-CCR5 antibodyPROGENICS PHARM INC·Filed 2006·Granted Dec 14, 2010·3 cites·27 claims
- 3982US7736649B2Methods of inhibiting human immunodeficiency virus infection through the administration of synergistic combinations of anti-CCR5 monoclonal antibodies, fusion inhibitors, and CD4-GP120 binding inhibitorsPROGENICS PHARM INC·Filed 2006·Granted Jun 15, 2010·1 cites·23 claims
- 4081US9102680B2Crystal forms of (R)-N-methylnaltrexone bromide and uses thereofPROGENICS PHARM INC·Filed 2012·Granted Aug 11, 2015·4 cites·14 claims
- 4180US8003794B2(S)-N-methylnaltrexonePROGENICS PHARM INC·Filed 2009·Granted Aug 23, 2011·4 cites·12 claims
- 4279US7479553B2Nucleic acids encoding mutant disulfide bond-stabilized human immunodeficiency virus type 1 (HIV-1) gp140 envelope glycoproteinsPROGENICS PHARM INC·Filed 2004·Granted Jan 20, 2009·4 cites·52 claims
- 4378US7022323B2Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infectionPROGENICS PHARM INC·Filed 2002·Granted Apr 4, 2006·3 cites·23 claims
- 4477US7935797B2CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusionPROGENICS PHARM INC·Filed 2007·Granted May 3, 2011·1 cites·1 claims
- 4577US6972126B2Methods for using resonance energy transfer-based assay of HIV-1 envelope glycoprotein-mediated membrane fusion, and kits for practicing samePROGENICS PHARM INC·Filed 1999·Granted Dec 6, 2005·33 cites·3 claims
- 4676US6737267B2Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereofPROGENICS PHARM INC·Filed 2001·Granted May 18, 2004·3 cites·48 claims
- 4773US12032722B2Systems and methods for secure cloud-based medical image upload and processingPROGENICS PHARM INC·Filed 2022·Granted Jul 9, 2024·0 cites·22 claims
- 4873US8916706B2Preparation and use of (R),(R)-2,2′-bis-methylnaltrexonePROGENICS PHARM INC·Filed 2013·Granted Dec 23, 2014·2 cites·30 claims
- 4972US9879024B2Crystal forms of (R)-N-methylnaltrexone bromide and uses thereofPROGENICS PHARM INC·Filed 2015·Granted Jan 30, 2018·1 cites·30 claims
- 5070US2007274986A1Compositions comprising anti-CCR5 antibodyPROGENICS PHARM INC·Filed 2007·Application pending·0 cites
Showing the top 50 of 94 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →